Trianni, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2011, the company has established itself as a pioneer in the development of advanced antibody discovery technologies, particularly through its proprietary Trianni Mouse platform. Trianni's core offerings include high-quality monoclonal antibodies that are uniquely engineered for specificity and efficacy, catering to the needs of researchers in pharmaceuticals and diagnostics. The company has achieved notable milestones, including collaborations with major pharmaceutical firms, solidifying its position as a trusted partner in the biopharmaceutical industry. With a commitment to scientific excellence and innovation, Trianni, Inc. continues to drive advancements in therapeutic development and research applications.
We don't have data for Trianni, Inc., but we can show you information about their parent organization instead.
View parent company